The biotechnology sector is in focus following reports that AbbVie (ABBV) is nearing an acquisition of Apogee Therapeutics ...

New biotech stock Kardigan may reveal Wall Street’s next move ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

The drug and biotech sector is in a recovery mode, after going through a difficult period between 2022 and 2024, backed by ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CNBC’s “Closing Bell Overtime” team discusses where the best opportunities are in pharma and biotech stocks with Evan ...

The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the ...

Biotech stocks combine scientific innovation with substantial R&D investment in cutting edge medicine. Biotech sector includes companies focused on gene editing and breakthroughs in rare disease ...

Biotech stocks combine scientific innovation with substantial R&D investment in cutting edge medicine. Biotech sector includes companies focused on gene editing and breakthroughs in rare disease ...